Riverside sells HRA Pharma to Astorg, Goldman Sachs

The Riverside Company and the company’s founders have sold French pharmaceutical company HRA Pharma to Goldman Sachs and European private equity firm Astorg. Financial terms of the transaction were not disclosed. Riverside invested in HRA in 2011.

19 February 2016•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles